07:00 , Sep 10, 2007 |  BC Week In Review  |  Company News

American Oriental, Changchun Xinan Pharmaceutical Group Co. Ltd. deal

AOB acquired Changchun for $28.5 million in cash. Changchun has about 40 plant-based branded prescription and OTC products on the market, including Nubao, a marketed blood circulation enhancer to treat premenstrual syndrome (PMS). AOB believes...
07:00 , May 14, 2007 |  BioCentury  |  Finance

Playing the China market

Look for more Chinese drug companies to go public on U.S. stock exchanges this year, as many of these companies hope to become aggregators in what is a fragmented market - and they like the...